Molecular Devices launches new environmental control and z-stack acquisition for ImageXpress Pico Automated Cell Imaging System

Dec 11, 2018

New features enable live cell imaging and 3D acquisition in an easy to use system to better address phenotypic imaging

Molecular Devices announced several new features including environmental control and z-stack acquisition for the ImageXpress® Pico system, highlighted at ASCB | EMBO 2018, December 8-12 in San Diego, California. Scientists can now monitor and run live cell and timelapse assays as well as capture sharper images for deeper insights in 3D models.

The fully integrated environmental control (EC) option utilizes both humidity and real-time gas monitoring to promote healthy cell growth during long exposure experiments. The system includes CellReporterXpress™ Automated Imaging and Analysis Software with preconfigured analysis modules including the new double marker expression algorithm for multi-parametric analysis.  Scientists can now leverage plug and play image visualization for 3D cell models with the new Z-stack acquisition module.

 “We strive to continually evolve our products to match our customers’ needs. These new features enable scientists to expand their research to include more relevant cell model systems and more complex analysis at an affordable price point,” said Jeff McMillan, Senior Product Manager for Cellular Imaging at Molecular Devices.

Molecular Devices delivers a diverse imaging portfolio to allow scientists easier access to protein and cell biology tools to advance their discoveries.

To learn more about all the features being introduced at the show, visit the website at moleculardevices.com/pico.

About Molecular Devices, LLC

Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.

Contact Information:

Sarah Vargas-Hurlston
Sr. Director of Marketing, Drug Discovery
408.203.8692
sarah.vargas-hurlston@moldev.com